<code id='91863135F4'></code><style id='91863135F4'></style>
    • <acronym id='91863135F4'></acronym>
      <center id='91863135F4'><center id='91863135F4'><tfoot id='91863135F4'></tfoot></center><abbr id='91863135F4'><dir id='91863135F4'><tfoot id='91863135F4'></tfoot><noframes id='91863135F4'>

    • <optgroup id='91863135F4'><strike id='91863135F4'><sup id='91863135F4'></sup></strike><code id='91863135F4'></code></optgroup>
        1. <b id='91863135F4'><label id='91863135F4'><select id='91863135F4'><dt id='91863135F4'><span id='91863135F4'></span></dt></select></label></b><u id='91863135F4'></u>
          <i id='91863135F4'><strike id='91863135F4'><tt id='91863135F4'><pre id='91863135F4'></pre></tt></strike></i>

          fashion

          fashion

          author:leisure time    Page View:1
          Johnson & Johnson sign
          MARK RALSTON/AFP via Getty Images

          WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

          J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

          advertisement

          The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Psilocybin's anti
          Psilocybin's anti

          AdobeAsingledoseofpsilocybinmayhaveenduringbenefitsforpeoplewithmajordepressivedisorder,accordingtoa

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

          7:36JonHuntsmanlistenstoquestionsduringahearingaboutvotingrightsintheDistrictofColumbiabeforetheCons